WO2001055107A3 - Aromatic amines and amides acting on the melanocortin receptors - Google Patents
Aromatic amines and amides acting on the melanocortin receptors Download PDFInfo
- Publication number
- WO2001055107A3 WO2001055107A3 PCT/GB2001/000356 GB0100356W WO0155107A3 WO 2001055107 A3 WO2001055107 A3 WO 2001055107A3 GB 0100356 W GB0100356 W GB 0100356W WO 0155107 A3 WO0155107 A3 WO 0155107A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- aromatic amines
- melanocortin receptors
- amides
- amides acting
- acting
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/40—Acylated substituent nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/34—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
- C07C233/35—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/40—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to an acyclic carbon atom of a carbon skeleton containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
- C07C237/06—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/04—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
- C07C279/14—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/12—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D209/20—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals substituted additionally by nitrogen atoms, e.g. tryptophane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/61—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Indole Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2001228681A AU2001228681A1 (en) | 2000-01-28 | 2001-01-29 | Novel aromatic amines and amides acting on the melanocortin receptors |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0002056A GB0002056D0 (en) | 2000-01-28 | 2000-01-28 | Novel aromatic amines |
GB0002058.6 | 2000-01-28 | ||
GB0002058A GB0002058D0 (en) | 2000-01-28 | 2000-01-28 | Novel aromatic amines |
GB0002056.0 | 2000-01-28 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2001055107A2 WO2001055107A2 (en) | 2001-08-02 |
WO2001055107A3 true WO2001055107A3 (en) | 2002-01-17 |
Family
ID=26243512
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB2001/000356 WO2001055107A2 (en) | 2000-01-28 | 2001-01-29 | Aromatic amines and amides acting on the melanocortin receptors |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2001228681A1 (en) |
WO (1) | WO2001055107A2 (en) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DZ3415A1 (en) | 2000-08-31 | 2002-03-07 | Chiron Corp | GUANIDINOBENZAMIDES AS MC4-R AGONISTS. |
WO2002028831A1 (en) * | 2000-10-02 | 2002-04-11 | Merck & Co., Inc. | Inhibitors of prenyl-protein transferase |
AU2002238106A1 (en) | 2001-02-13 | 2002-08-28 | Palatin Technologies, Inc. | Melanocortin metallopeptides for treatment of sexual dysfunction |
US7456183B2 (en) | 2001-04-09 | 2008-11-25 | Novartis Vaccines And Diagnostics, Inc. | Guanidino compounds |
AU2002331064B2 (en) | 2001-08-10 | 2007-08-23 | Palatin Technologies, Inc. | Peptidomimetics of biologically active metallopeptides |
US7319107B2 (en) | 2001-11-08 | 2008-01-15 | Johnson & Johnson Consumer Companies, Inc. | 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators |
DK1446394T3 (en) | 2001-11-08 | 2007-03-12 | Ortho Mcneil Pharm Inc | Newly known 1,2,4-thiadiazole derivatives as melanocortin receptor modulators |
US20030195187A1 (en) * | 2002-02-04 | 2003-10-16 | Chiron Corporation | Guanidino compounds |
US6858637B2 (en) | 2002-03-28 | 2005-02-22 | Neurogen Corporation | Substituted biaryl amides as C5a receptor modulators |
PT1551834E (en) | 2002-05-23 | 2010-09-30 | Novartis Vaccines & Diagnostic | Substituted quinazolinone compounds |
US7649011B2 (en) * | 2002-12-20 | 2010-01-19 | Chemocentryx, Inc. | Inhibitors of human tumor-expressed CCXCKR2 |
US7625909B2 (en) | 2003-05-23 | 2009-12-01 | Novartis Vaccines And Diagnostics, Inc. | Substituted quinazolinone compounds |
MXPA06005736A (en) | 2003-11-19 | 2006-12-14 | Chiron Corp | Quinazolinone compounds with reduced bioaccumulation. |
WO2005059558A2 (en) * | 2003-12-11 | 2005-06-30 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with g protein-coupled receptor mc4 (mc4) |
US8314256B2 (en) | 2005-10-06 | 2012-11-20 | Vertex Pharmaceuticals Incorporated | Modulators of ATP-binding cassette transporters |
WO2007141343A1 (en) | 2006-06-09 | 2007-12-13 | Action Pharma A/S | Phenyl pyrrole aminoguanidine derivatives |
GB0624987D0 (en) | 2006-12-14 | 2007-01-24 | Acure Pharma Ab | Novel aminoguanidines as melanocortin receptor ligands |
EP2278962B1 (en) | 2008-02-21 | 2014-02-12 | Janssen Pharmaceutica N.V. | Methods for the treatment of dermatological disorders |
CN103877423A (en) * | 2014-04-08 | 2014-06-25 | 张利民 | Medicine for treating wind-cold pneumorrhagia-nephritic syndrome |
Citations (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2049377A1 (en) * | 1969-10-10 | 1971-04-22 | S A Manufactures J R Bottu, Pans | Pharmaceutical preparations |
FR2073286A1 (en) * | 1969-12-23 | 1971-10-01 | Robert Et Carriere Labo | Substd anilines - with antirheumatic analgesic and antiinflammatory activity |
EP0017376A1 (en) * | 1979-03-30 | 1980-10-15 | Kissei Pharmaceutical Co. Ltd | Phenylacetamide compounds and an analgesic composition containing them |
US4468448A (en) * | 1983-06-02 | 1984-08-28 | Polaroid Corporation | Photographic products and processes |
US4579866A (en) * | 1984-05-29 | 1986-04-01 | Usv Pharmaceutical Corp. | Phenylacetamides as anti-allergy, anti-asthma and anti-inflammatory agents |
EP0277755A1 (en) * | 1987-01-30 | 1988-08-10 | Kissei Pharmaceutical Co. Ltd. | 4H-quinolizin-4-one compounds exhibiting therapeutic activities |
US4803063A (en) * | 1987-04-16 | 1989-02-07 | Atochem | Process for the cyclic production of hydrogen peroxide |
EP0318944A2 (en) * | 1987-12-04 | 1989-06-07 | EASTMAN KODAK COMPANY (a New Jersey corporation) | Increasing dye transfer efficiency in dye-donor elements used in thermal dye transfer |
EP0334538A1 (en) * | 1988-03-25 | 1989-09-27 | The Upjohn Company | Therapeutically useful tetralin derivatives |
US5180796A (en) * | 1990-02-26 | 1993-01-19 | Phillips Petroleum Company | Derivatization of arylene sulfide polymers |
US5288749A (en) * | 1991-12-20 | 1994-02-22 | Abbott Laboratories | Tertiary and secondary amines as alpha-2 antagonists and serotonin uptake inhibitors |
EP0613879A1 (en) * | 1991-05-20 | 1994-09-07 | TSUMURA & CO. | Phellodendrine analogs and allergy type iv suppressor containing the same as active ingredient |
US5571832A (en) * | 1992-11-13 | 1996-11-05 | The United States Of America As Represented By The Department Of Health And Human Services | Nitrogen-containing cyclohetero alkylamino aryl derivatives for CNS disorders |
WO1997042230A1 (en) * | 1996-05-03 | 1997-11-13 | Warner-Lambert Company | Rapid purification by polymer supported quench |
WO1998007692A1 (en) * | 1996-08-17 | 1998-02-26 | Zeneca Limited | 3-mercaptopyrrolidines as farnesyl protein transferase inhibitors |
WO1998050029A1 (en) * | 1997-05-07 | 1998-11-12 | University Of Pittsburgh | Inhibitors of protein isoprenyl transferases |
WO1999001423A1 (en) * | 1997-07-01 | 1999-01-14 | Novo Nordisk A/S | Glucagon antagonists/inverse agonists |
WO1999021571A1 (en) * | 1997-10-27 | 1999-05-06 | Trega Biosciences, Inc. | Melanocortin receptor ligands and methods of using same |
WO1999044987A1 (en) * | 1998-03-05 | 1999-09-10 | Agouron Pharmaceuticals, Inc. | NON-PEPTIDE GnRH AGENTS |
WO1999055679A1 (en) * | 1998-04-28 | 1999-11-04 | Trega Biosciences, Inc. | Isoquinoline compound melanocortin receptor ligands and methods of using same |
WO1999064002A1 (en) * | 1998-06-11 | 1999-12-16 | Merck & Co., Inc. | Spiropiperidine derivatives as melanocortin receptor agonists |
-
2001
- 2001-01-29 AU AU2001228681A patent/AU2001228681A1/en not_active Abandoned
- 2001-01-29 WO PCT/GB2001/000356 patent/WO2001055107A2/en active Application Filing
Patent Citations (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2049377A1 (en) * | 1969-10-10 | 1971-04-22 | S A Manufactures J R Bottu, Pans | Pharmaceutical preparations |
FR2073286A1 (en) * | 1969-12-23 | 1971-10-01 | Robert Et Carriere Labo | Substd anilines - with antirheumatic analgesic and antiinflammatory activity |
EP0017376A1 (en) * | 1979-03-30 | 1980-10-15 | Kissei Pharmaceutical Co. Ltd | Phenylacetamide compounds and an analgesic composition containing them |
US4468448A (en) * | 1983-06-02 | 1984-08-28 | Polaroid Corporation | Photographic products and processes |
US4579866A (en) * | 1984-05-29 | 1986-04-01 | Usv Pharmaceutical Corp. | Phenylacetamides as anti-allergy, anti-asthma and anti-inflammatory agents |
EP0277755A1 (en) * | 1987-01-30 | 1988-08-10 | Kissei Pharmaceutical Co. Ltd. | 4H-quinolizin-4-one compounds exhibiting therapeutic activities |
US4803063A (en) * | 1987-04-16 | 1989-02-07 | Atochem | Process for the cyclic production of hydrogen peroxide |
EP0318944A2 (en) * | 1987-12-04 | 1989-06-07 | EASTMAN KODAK COMPANY (a New Jersey corporation) | Increasing dye transfer efficiency in dye-donor elements used in thermal dye transfer |
EP0334538A1 (en) * | 1988-03-25 | 1989-09-27 | The Upjohn Company | Therapeutically useful tetralin derivatives |
US5180796A (en) * | 1990-02-26 | 1993-01-19 | Phillips Petroleum Company | Derivatization of arylene sulfide polymers |
EP0613879A1 (en) * | 1991-05-20 | 1994-09-07 | TSUMURA & CO. | Phellodendrine analogs and allergy type iv suppressor containing the same as active ingredient |
US5288749A (en) * | 1991-12-20 | 1994-02-22 | Abbott Laboratories | Tertiary and secondary amines as alpha-2 antagonists and serotonin uptake inhibitors |
US5571832A (en) * | 1992-11-13 | 1996-11-05 | The United States Of America As Represented By The Department Of Health And Human Services | Nitrogen-containing cyclohetero alkylamino aryl derivatives for CNS disorders |
WO1997042230A1 (en) * | 1996-05-03 | 1997-11-13 | Warner-Lambert Company | Rapid purification by polymer supported quench |
WO1998007692A1 (en) * | 1996-08-17 | 1998-02-26 | Zeneca Limited | 3-mercaptopyrrolidines as farnesyl protein transferase inhibitors |
WO1998050029A1 (en) * | 1997-05-07 | 1998-11-12 | University Of Pittsburgh | Inhibitors of protein isoprenyl transferases |
WO1999001423A1 (en) * | 1997-07-01 | 1999-01-14 | Novo Nordisk A/S | Glucagon antagonists/inverse agonists |
WO1999021571A1 (en) * | 1997-10-27 | 1999-05-06 | Trega Biosciences, Inc. | Melanocortin receptor ligands and methods of using same |
WO1999044987A1 (en) * | 1998-03-05 | 1999-09-10 | Agouron Pharmaceuticals, Inc. | NON-PEPTIDE GnRH AGENTS |
WO1999055679A1 (en) * | 1998-04-28 | 1999-11-04 | Trega Biosciences, Inc. | Isoquinoline compound melanocortin receptor ligands and methods of using same |
WO1999064002A1 (en) * | 1998-06-11 | 1999-12-16 | Merck & Co., Inc. | Spiropiperidine derivatives as melanocortin receptor agonists |
Non-Patent Citations (1)
Title |
---|
R.C. WEAST (EDITOR): "Handbook of Chemistry and Physics, 52nd edition", 1971, THE CHEMICAL RUBBER CO., CLEVELAND, OHIO, US, XP002171193 * |
Also Published As
Publication number | Publication date |
---|---|
WO2001055107A2 (en) | 2001-08-02 |
AU2001228681A1 (en) | 2001-08-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2001055106A3 (en) | Novel melanocortin receptor agonists and antagonists | |
WO2001055107A3 (en) | Aromatic amines and amides acting on the melanocortin receptors | |
IS5085A (en) | Nasal conjunctiva for the treatment of sexual disorders | |
ECSP045081A (en) | DERIVATIVES OF 1,8-NAFTIRIDINE AND ITS USE FOR THE TREATMENT OF DIABETES AND RELATED DISORDERS | |
AU2003299791A1 (en) | Substituted 3,5-dihydro-4h-imidazol-4-ones for the treatment of obesity | |
IS6003A (en) | Monoamine reuptake inhibitors for the treatment of central nervous system disorders | |
NO20035025D0 (en) | Use of osteopontin for treatment and / or prevention of neurological disorders | |
NO20034996D0 (en) | New arylsus phonamide compounds for the treatment of obesity, type II diabetes and CNS disorders | |
WO2006047516A3 (en) | Compounds and compositions as inhibitors of cannabinoid receptor 1 activity | |
AU2003281978A1 (en) | 2,5-diketopiperazines for the treatment of obesity | |
ZA200309977B (en) | Arylamines for the treatment of conditions associated with GSK-3. | |
WO2004009034A3 (en) | Thiomolybdate analogues and uses thereof | |
MXPA04004714A (en) | Substituted aryl 1,4-pyrazine derivatives. | |
WO2005007111A3 (en) | Tetrahydroquinoline derivatives as cannabinoid receptor modulators | |
ZA200109073B (en) | Compositions for treatment of disorders of the oesophagus. | |
PL377296A1 (en) | 1,5-diaryl-pyrrole-3-carboxamide derivatives and their use as cannabinoid receptor modulators | |
EP1978068A3 (en) | Adhesive Structures for Attachment to Skin | |
IL165051A0 (en) | New compounds useful for the treatment of obesity,type II diabetes and cns disorders | |
PL367142A1 (en) | 4 (phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders | |
DK1339406T3 (en) | Piperazine derivatives, processes for their preparation and use thereof for the treatment of central nervous system disorders | |
EP1625207A4 (en) | Compounds for treatment of inflammation, diabetes and related disorders | |
WO2003088748A8 (en) | Use of heme oxygenase-1 and products of heme degradation | |
ZA200501288B (en) | Substituted 5-chroman-5-yl-ethylamine compounds and their use for the treatment of glaucoma. | |
HUP0201791A2 (en) | The use of escitalopram for treatment of neurotic disorders | |
AU2003303217A8 (en) | Use of substituted 2,5-diamidoindoles for the treatment of urological diseases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |